557 related articles for article (PubMed ID: 30988123)
1. Bacteremia in Systemic Lupus Erythematosus in Patients from a Spanish Registry: Risk Factors, Clinical and Microbiological Characteristics, and Outcomes.
Rúa-Figueroa I; López-Longo FJ; Del Campo V; Galindo-Izquierdo M; Uriarte E; Torre-Cisneros J; Vela P; Tomero E; Narváez J; Olivé A; Freire M; Salgado E; Andreu JL; Martínez-Taboada V; Calvo-Alén J; Hernández-Cruz B; Raya E; Quevedo V; Expósito Pérez L; Fernández-Nebro A; Ibañez M; Pascual-Valls È; Rúa-Figueroa D; Naranjo A; Pego-Reigosa JM
J Rheumatol; 2020 Feb; 47(2):234-240. PubMed ID: 30988123
[TBL] [Abstract][Full Text] [Related]
2. Incidence, associated factors and clinical impact of severe infections in a large, multicentric cohort of patients with systemic lupus erythematosus.
Rúa-Figueroa Í; López-Longo J; Galindo-Izquierdo M; Calvo-Alén J; Del Campo V; Olivé-Marqués A; Pérez-Vicente S; Fernández-Nebro A; Andrés M; Erausquin C; Tomero E; Horcada L; Uriarte E; Freire M; Montilla C; Sánchez-Atrio A; Santos G; Boteanu A; Díez-Álvarez E; Narváez J; Martínez-Taboada V; Silva-Fernández L; Ruiz-Lucea E; Andreu JL; Hernández-Beriain JÁ; Gantes M; Hernández-Cruz B; Pérez-Venegas J; Pecondón-Español Á; Marras C; Ibáñez-Barceló M; Bonilla G; Torrente V; Castellví I; Alegre JJ; Calvet J; Marenco JL; Raya E; Vázquez T; Quevedo V; Muñoz-Fernández S; Rodríguez-Gómez M; Ibáñez J; Pego-Reigosa JM
Semin Arthritis Rheum; 2017 Aug; 47(1):38-45. PubMed ID: 28259425
[TBL] [Abstract][Full Text] [Related]
3. Corticosteroid dose and the risk of opportunistic infection in a national systemic lupus erythematosus cohort.
Yang SC; Lai YY; Huang MC; Tsai CS; Wang JL
Lupus; 2018 Oct; 27(11):1819-1827. PubMed ID: 30103646
[TBL] [Abstract][Full Text] [Related]
4. Associated factors to serious infections in a large cohort of juvenile-onset systemic lupus erythematosus from Lupus Registry (RELESSER).
Torrente-Segarra V; Salman-Monte TC; Rúa-Figueroa Í; Del Campo V; López-Longo FJ; Galindo-Izquierdo M; Calvo-Alén J; Olivé-Marqués A; Mouriño-Rodríguez C; Horcada L; Bohórquez C; Montilla C; Salgado E; Díez-Álvarez E; Blanco R; Andreu JL; Fernández-Berrizbeitia O; Expósito L; Gantes M; Hernández-Cruz B; Pecondón-Español Á; Lozano-Rivas N; Bonilla G; Lois Iglesias A; Rubio-Muñoz P; Ovalles J; Tomero E; Boteanu A; Narvaez J; Freire M; Vela P; Quevedo-Vila V; Juan Mas A; Muñoz-Fernández S; Raya E; Moreno M; Velloso-Feijoo ML; Soler G; Vázquez-Rodríguez TR; Pego-Reigosa JM;
Semin Arthritis Rheum; 2020 Aug; 50(4):657-662. PubMed ID: 32505871
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effect of cumulative corticosteroid dose and immunosuppressants on avascular necrosis in patients with systemic lupus erythematosus.
Kwon HH; Bang SY; Won S; Park Y; Yi JH; Joo YB; Lee HS; Bae SC
Lupus; 2018 Sep; 27(10):1644-1651. PubMed ID: 29950160
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive description of clinical characteristics of a large systemic lupus erythematosus cohort from the Spanish Rheumatology Society Lupus Registry (RELESSER) with emphasis on complete versus incomplete lupus differences.
Rúa-Figueroa Í; Richi P; López-Longo FJ; Galindo M; Calvo-Alén J; Olivé-Marqués A; Loza-Santamaría E; Vicente SP; Erausquin C; Tomero E; Horcada L; Uriarte E; Sánchez-Atrio A; Rosas J; Montilla C; Fernández-Nebro A; Rodríguez-Gómez M; Vela P; Blanco R; Freire M; Silva L; Díez-Álvarez E; Ibáñez-Barceló M; Zea A; Narváez J; Martínez-Taboada V; Marenco JL; de Castro MF; Fernández-Berrizbeitia O; Hernández-Beriain JÁ; Gantes M; Hernández-Cruz B; Pérez-Venegas JJ; Pecondón Á; Marras C; Carreira P; Bonilla G; Torrente V; Castellví I; Alegre J; Moreno M; Raya E; de la Peña PG; Vázquez T; Aguirre Á; Quevedo V; Pego-Reigosa JM;
Medicine (Baltimore); 2015 Jan; 94(1):e267. PubMed ID: 25569641
[TBL] [Abstract][Full Text] [Related]
7. Charlson Comorbidity Index Is Related to Organ Damage in Systemic Lupus Erythematosus: Data from KORean lupus Network (KORNET) Registry.
Kim SK; Choe JY; Lee SS
J Rheumatol; 2017 Apr; 44(4):452-458. PubMed ID: 28298561
[TBL] [Abstract][Full Text] [Related]
8. Predictors of organ damage in systemic lupus erythematosus: the Hopkins Lupus Cohort.
Petri M; Purvey S; Fang H; Magder LS
Arthritis Rheum; 2012 Dec; 64(12):4021-8. PubMed ID: 22932985
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the safety profile of calcineurin inhibitors: cancer risk in patients with systemic lupus erythematosus from the LUNA registry-a historical cohort study.
Ichinose K; Sato S; Igawa T; Okamoto M; Takatani A; Endo Y; Tsuji S; Shimizu T; Sumiyoshi R; Koga T; Kawashiri SY; Iwamoto N; Tamai M; Nakamura H; Origuchi T; Yajima N; Sada KE; Miyawaki Y; Yoshimi R; Shimojima Y; Ohno S; Kajiyama H; Sato S; Fujiwara M; Kawakami A
Arthritis Res Ther; 2024 Feb; 26(1):48. PubMed ID: 38347556
[TBL] [Abstract][Full Text] [Related]
10. Primary respiratory disease in patients with systemic lupus erythematosus: data from the Spanish rheumatology society lupus registry (RELESSER) cohort.
Narváez J; Borrell H; Sánchez-Alonso F; Rúa-Figueroa I; López-Longo FJ; Galindo-Izquierdo M; Calvo-Alén J; Fernández-Nebro A; Olivé A; Andreu JL; Martínez-Taboada V; Nolla JM; Pego-Reigosa JM;
Arthritis Res Ther; 2018 Dec; 20(1):280. PubMed ID: 30567600
[TBL] [Abstract][Full Text] [Related]
11. Systemic lupus erythematosus in Spanish males: a study of the Spanish Rheumatology Society Lupus Registry (RELESSER) cohort.
Riveros Frutos A; Casas I; Rúa-Figueroa I; López-Longo FJ; Calvo-Alén J; Galindo M; Fernández-Nebro A; Pego-Reigosa JM; Olivé Marqués A;
Lupus; 2017 Jun; 26(7):698-706. PubMed ID: 27799439
[TBL] [Abstract][Full Text] [Related]
12. Increased congenital heart defects in children born to women with systemic lupus erythematosus: results from the offspring of Systemic Lupus Erythematosus Mothers Registry Study.
Vinet É; Pineau CA; Scott S; Clarke AE; Platt RW; Bernatsky S
Circulation; 2015 Jan; 131(2):149-56. PubMed ID: 25355915
[TBL] [Abstract][Full Text] [Related]
13. A Multicenter Study of Invasive Fungal Infections in Patients with Childhood-onset Systemic Lupus Erythematosus.
Silva MF; Ferriani MP; Terreri MT; Pereira RM; Magalhães CS; Bonfá E; Campos LM; Okuda EM; Appenzeller S; Ferriani VP; Barbosa CM; Ramos VC; Lotufo S; Silva CA
J Rheumatol; 2015 Dec; 42(12):2296-303. PubMed ID: 26568586
[TBL] [Abstract][Full Text] [Related]
14. Late-onset systemic lupus erythematosus: characteristics and outcome in comparison to juvenile- and adult-onset patients-a multicenter retrospective cohort.
Medhat BM; Behiry ME; Sobhy N; Farag Y; Marzouk H; Mostafa N; Khalifa I; Elkhalifa M; Eissa BM; Hassan EHE
Clin Rheumatol; 2020 Feb; 39(2):435-442. PubMed ID: 31758421
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage.
Brunner HI; Silverman ED; To T; Bombardier C; Feldman BM
Arthritis Rheum; 2002 Feb; 46(2):436-44. PubMed ID: 11840446
[TBL] [Abstract][Full Text] [Related]
16. Comorbidities in Patients With Primary Sjögren's Syndrome and Systemic Lupus Erythematosus: A Comparative Registries-Based Study.
Rúa-Figueroa I; Fernández Castro M; Andreu JL; Sanchez-Piedra C; Martínez-Taboada V; Olivé A; López-Longo J; Rosas J; Galindo M; Calvo-Alén J; Fernández-Nebro A; Alonso F; Rodríguez-Lozano B; Alberto García Vadillo J; Menor R; Narváez FJ; Erausquin C; García-Aparicio Á; Tomero E; Manrique-Arija S; Horcada L; Uriarte E; Gil S; Blanco R; López-González R; Boteanu A; Freire M; Galisteo C; Rodríguez-Gómez M; Díez-Álvarez E; Pego-Reigosa JM;
Arthritis Care Res (Hoboken); 2017 Jan; 69(1):38-45. PubMed ID: 27564390
[TBL] [Abstract][Full Text] [Related]
17. Clinical impact of hydroxychloroquine dose adjustment according to the American Academy of Ophthalmology guidelines in systemic lupus erythematosus.
Vázquez-Otero I; Medina-Cintrón N; Arroyo-Ávila M; González-Sepúlveda L; Vilá LM
Lupus Sci Med; 2020 May; 7(1):. PubMed ID: 32434863
[TBL] [Abstract][Full Text] [Related]
18. National registry of patients with systemic lupus erythematosus of the Spanish Society of Rheumatology: objectives and methodology.
Rúa-Figueroa I; López-Longo FJ; Calvo-Alén J; Galindo-Izquierdo M; Loza E; García de Yebenes MJ; Pego-Reigosa JM; ;
Reumatol Clin; 2014; 10(1):17-24. PubMed ID: 23871155
[TBL] [Abstract][Full Text] [Related]
19. Associations of clinical features and prognosis with age at disease onset in patients with systemic lupus erythematosus.
Feng X; Zou Y; Pan W; Wang X; Wu M; Zhang M; Tao J; Zhang Y; Tan K; Li J; Chen Z; Ding X; Qian X; Da Z; Wang M; Sun L
Lupus; 2014 Mar; 23(3):327-34. PubMed ID: 24297642
[TBL] [Abstract][Full Text] [Related]
20. The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort.
Conti F; Ceccarelli F; Perricone C; Leccese I; Massaro L; Pacucci VA; Truglia S; Miranda F; Spinelli FR; Alessandri C; Valesini G
Lupus; 2016 Jun; 25(7):719-26. PubMed ID: 26821965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
